151 related articles for article (PubMed ID: 26741162)
21. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
[TBL] [Abstract][Full Text] [Related]
22. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells.
Zhang H; Tang J; Li C; Kong J; Wang J; Wu Y; Xu E; Lai M
Cancer Lett; 2015 Jan; 356(2 Pt B):781-90. PubMed ID: 25449431
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
[TBL] [Abstract][Full Text] [Related]
24. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
26. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts.
Liu L; Chang S; Sun J; Zhu S; Yin M; Zhu Y; Wang Z; Xu RX
Cancer Lett; 2015 May; 361(1):147-54. PubMed ID: 25754815
[TBL] [Abstract][Full Text] [Related]
28. Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells.
Wu C; Xu J; Hao Y; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P; Liu Y
Int J Nanomedicine; 2017; 12():7979-7992. PubMed ID: 29184399
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
30. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
32. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
33. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
[TBL] [Abstract][Full Text] [Related]
34. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
Kang MR; Yang G; Place RF; Charisse K; Epstein-Barash H; Manoharan M; Li LC
Cancer Res; 2012 Oct; 72(19):5069-79. PubMed ID: 22869584
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
[TBL] [Abstract][Full Text] [Related]
36. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
37. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
[TBL] [Abstract][Full Text] [Related]
38. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.
Smitha KT; Anitha A; Furuike T; Tamura H; Nair SV; Jayakumar R
Colloids Surf B Biointerfaces; 2013 Apr; 104():245-53. PubMed ID: 23337120
[TBL] [Abstract][Full Text] [Related]
40. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]